The regulator had asked Sarepta Therapeutics to halt all shipments of its therapy, Elevidys, after three patients died from liver failure after taking it or a similar treatment. Post navigation Anti-Israel protester tackled by security at Tour de France finish lineWoman at center of Coldplay concert cuddling video is married to another powerful CEO